EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC 4.0

An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder ( EBRUC) II trial

Julian Peter Struck, Nadim Moharam iD, Armin Leitenberger, Jörg Weber, Lukas Lusuardi, David Oswald, Jens J Rassweiler, Marcel Fiedler, Jakub Horňák, Marek Babjuk, Salvatore Micali, Carlo Zaraca und 5 weitere

BJU International · 2025-03 · 135 (3) · 446-455

DOI: 10.1111/bju.16543 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 27.10.2024. Verfasst von Julian Peter Struck und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the safety and oncological advantages of en bloc resection of bladder tumour (ERBT) vs conventional transurethral resection of bladder tumour (cTURBT) in terms of resection quality, staging quality, and safety. Patients and Methods We conducted a single‐blinded randomised controlled trial at seven European hospitals with the following inclusion criteria: first diagnosis of non‐muscle‐invasive bladder cancer, no singular carcinoma in situ , and tumour size >4.3 mm. Patients were randomised intraoperatively in a 1:1 ratio to either the ERBT or cTURBT group. Outcome analysis was performed using the chi‐square test, t ‐test, and multivariate regression analysis.

Results

A total of 97 patients were randomised into the study (cTURBT = 40, ERBT = 57). A switch to cTURBT was necessary in two patients (3.5%) and 11.5% of the screened patients were preoperatively excluded for ERBT. There was no difference in the specimen presence of detrusor muscle with 73.7% in cTURBT and 67.3% in ERBT specimens ( P = 0.69). There were no significant differences in mean operative time (ERBT 27.6 vs cTURBT 25.4 min, P = 0.450) or mean resection time (ERBT 16.3 vs cTURBT 15.5 min, P = 0.732). Overall the complication rate did not differ significantly (ERBT 18.2% vs cTURBT 7.5%, P = 0.142). Bladder perforations occurred significantly more often in the ERBT group (ERBT seven vs cTURBT none, P = 0.020). R0 status was reported more often after ERBT, whilst a second resection was significantly less frequent after ERBT ( P = 0.018). Recurrence rates were comparable for both techniques after 6 months of follow‐up.

Conclusion

The feasibility of ERBT is higher than previously reported. Whereas other perioperative and safety parameters are comparable to cTURBT, bladder perforations occurred significantly more often in the ERBT group and raised safety concerns. This is why this trial was terminated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyHumansMaleFemaleAgedMiddle AgedSingle-Blind MethodAged, 80 and overTreatment OutcomeTransurethral Resection of Bladder

Stichwörter der Autor:innen

EBRUC IIbladder canceren bloc resectionnon‐muscle‐invasive bladder cancertransurethral resection of bladder tumour

Autor:innen und Institutionen

  • Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Department of Urology, Brandenburg Medical School Theodor Fontane (MHB), Brandenburg an der Havel, Germany.
  • Department of Urology and Urologic Surgery, University Medical Centre Mannheim, Mannheim, Germany.
  • Department of Urology, Wolfsburg Hospital, Wolfsburg, Germany.
  • Department of Urology and Andrology, Salzburg University Hospital, Salzburg, Austria.
  • Department of Urology and Pediatric Urology, SLK-Klinikum, Heilbronn, Germany.

ORCID-Profile: Nadim Moharam

Zitieren

APA

Struck, J. P., Moharam, N., Leitenberger, A., Weber, J., Lusuardi, L., Oswald, D., Rassweiler, J. J., Fiedler, M., Horňák, J., Babjuk, M., Micali, S., Zaraca, C., Spreu, T., Friedersdorff, F., Borgmann, H., Merseburger, A. S., & Kramer, M. W. (2025). An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder ( EBRUC) II trial. BJU International, 135(3), 446-455. https://doi.org/10.1111/bju.16543

Vancouver

Struck JP, Moharam N, Leitenberger A, Weber J, Lusuardi L, Oswald D, et al. An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder ( EBRUC) II trial. BJU International. 2025;135(3):446-455. doi:10.1111/bju.16543

BibTeX
@article{Struck2025,
  author = {Struck, Julian Peter and Moharam, Nadim and Leitenberger, Armin and Weber, Jörg and Lusuardi, Lukas and Oswald, David and Rassweiler, Jens J and Fiedler, Marcel and Horňák, Jakub and Babjuk, Marek and Micali, Salvatore and Zaraca, Carlo and Spreu, Thomas and Friedersdorff, Frank and Borgmann, Hendrik and Merseburger, Axel S and Kramer, Mario W},
  title = {An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder ( EBRUC) II trial},
  journal = {BJU International},
  year = {2025},
  volume = {135},
  number = {3},
  pages = {446--455},
  doi = {10.1111/bju.16543}
}
Kostenlos starten →